Juan Ignacio Moliva, Ph.D.
About Juan Ignacio Moliva, Ph.D.
Juan Ignacio Moliva, Ph.D., is a Postdoctoral Scientist at the Vaccine Research Center within the National Institutes of Health, specializing in vaccine development for Ebola and SARS-CoV-2. He holds a Ph.D. in Biomedical Sciences - Immunology from The Ohio State University and a B.S. in Biochemistry & Molecular Biology from Penn State University.
Work at National Institutes of Health
Juan Ignacio Moliva, Ph.D., serves as a Postdoctoral Scientist in the Biodefense Research Section at the Vaccine Research Center, part of the National Institutes of Health (NIH) in Bethesda, Maryland. He has held this position since 2018, contributing to research focused on vaccine development. His work is particularly centered on addressing emerging infectious diseases, with a specific emphasis on vaccines for Ebola and SARS-CoV-2.
Education and Expertise
Juan Ignacio Moliva earned his Doctor of Philosophy in Biomedical Sciences with a focus on Immunology from The Ohio State University College of Medicine, where he studied from 2012 to 2017. Prior to that, he completed a Bachelor of Science in Biochemistry & Molecular Biology at Penn State University from 2008 to 2012. His educational background provides a strong foundation for his research in vaccine development and immunological responses.
Background
Before joining the NIH, Juan Ignacio Moliva worked as a Postdoctoral Scientist at the Texas Biomedical Research Institute in San Antonio, Texas. His role there focused on Tuberculosis Host-Pathogen Interaction from 2017 to 2018. This experience contributed to his expertise in infectious diseases and vaccine research, further shaping his career in biodefense and immunology.
Research Focus and Advocacy
Juan Ignacio Moliva has a strong commitment to advocating for the research, development, and use of vaccines. His current research primarily targets the development of vaccines for Ebola and SARS-CoV-2, reflecting his dedication to addressing global health challenges. His work in the Biodefense Research Section aims to enhance public health preparedness against infectious diseases.